ArticleFrontiers in molecular biosciences2021
ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis.
Qiang Yan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papertrialcites it